Previous News Items
for the Phase 3 Study of Dexpramipexole in ALS/MND. Inclusion criteria was very strict and numbers of people enrolled in Australia are small. This trial, however, is very significant for Australia as it is the first time Australians living with MND have been included in an international multi site clinical trial.
Click here for details of the trial and information about which sites are involved.